Vishwaraj Sugar Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 9:53 am

Competitors of Vishwaraj Sugar Industries Ltd

All Competitor Stocks of Vishwaraj Sugar Industries Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:20 am

Below is a detailed analysis of the quarterly data for Vishwaraj Sugar Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 133.00 Cr.. The value appears to be declining and may need further review. It has decreased from 167.00 Cr. (Mar 2025) to 133.00 Cr., marking a decrease of 34.00 Cr..
• For Expenses, as of Jun 2025, the value is 141.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 154.00 Cr. (Mar 2025) to 141.00 Cr., marking a decrease of 13.00 Cr..
• For Operating Profit, as of Jun 2025, the value is -8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2025) to -8.00 Cr., marking a decrease of 20.00 Cr..
• For OPM %, as of Jun 2025, the value is -6.00%. The value appears to be declining and may need further review. It has decreased from 7.00% (Mar 2025) to -6.00%, marking a decrease of 13.00%.
• For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 7.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Mar 2025) to -16.00 Cr., marking a decrease of 24.00 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 74.00% (Mar 2025) to 0.00%, marking a decrease of 74.00%.
• For Net Profit, as of Jun 2025, the value is -16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2025) to -16.00 Cr., marking a decrease of 18.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.75. The value appears to be declining and may need further review. It has decreased from 0.09 (Mar 2025) to -0.75, marking a decrease of 0.84.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:10 am

Growth

Last Updated: September 5, 2025, 1:51 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Vishwaraj Sugar Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -1.74. This value is below the healthy minimum of 5. It has decreased from 0.78 (Mar 24) to -1.74, marking a decrease of 2.52.
• For Diluted EPS (Rs.), as of Mar 25, the value is -1.74. This value is below the healthy minimum of 5. It has decreased from 0.78 (Mar 24) to -1.74, marking a decrease of 2.52.
• For Cash EPS (Rs.), as of Mar 25, the value is -0.95. This value is below the healthy minimum of 3. It has decreased from 1.62 (Mar 24) to -0.95, marking a decrease of 2.57.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 12.88. It has decreased from 14.29 (Mar 24) to 12.88, marking a decrease of 1.41.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 12.88. It has decreased from 14.29 (Mar 24) to 12.88, marking a decrease of 1.41.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 0.20 (Mar 24) to 0.00, marking a decrease of 0.20.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 20.84. It has decreased from 29.27 (Mar 24) to 20.84, marking a decrease of 8.43.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 2. It has decreased from 3.66 (Mar 24) to 0.88, marking a decrease of 2.78.
• For PBIT / Share (Rs.), as of Mar 25, the value is 0.14. This value is within the healthy range. It has decreased from 2.81 (Mar 24) to 0.14, marking a decrease of 2.67.
• For PBT / Share (Rs.), as of Mar 25, the value is -1.43. This value is below the healthy minimum of 0. It has decreased from 1.19 (Mar 24) to -1.43, marking a decrease of 2.62.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -1.70. This value is below the healthy minimum of 2. It has decreased from 0.77 (Mar 24) to -1.70, marking a decrease of 2.47.
• For PBDIT Margin (%), as of Mar 25, the value is 4.25. This value is below the healthy minimum of 10. It has decreased from 12.49 (Mar 24) to 4.25, marking a decrease of 8.24.
• For PBIT Margin (%), as of Mar 25, the value is 0.70. This value is below the healthy minimum of 10. It has decreased from 9.60 (Mar 24) to 0.70, marking a decrease of 8.90.
• For PBT Margin (%), as of Mar 25, the value is -6.84. This value is below the healthy minimum of 10. It has decreased from 4.05 (Mar 24) to -6.84, marking a decrease of 10.89.
• For Net Profit Margin (%), as of Mar 25, the value is -8.15. This value is below the healthy minimum of 5. It has decreased from 2.63 (Mar 24) to -8.15, marking a decrease of 10.78.
• For Return on Networth / Equity (%), as of Mar 25, the value is -13.20. This value is below the healthy minimum of 15. It has decreased from 5.40 (Mar 24) to -13.20, marking a decrease of 18.60.
• For Return on Capital Employeed (%), as of Mar 25, the value is 0.70. This value is below the healthy minimum of 10. It has decreased from 13.78 (Mar 24) to 0.70, marking a decrease of 13.08.
• For Return On Assets (%), as of Mar 25, the value is -4.52. This value is below the healthy minimum of 5. It has decreased from 1.81 (Mar 24) to -4.52, marking a decrease of 6.33.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.44. This value is within the healthy range. It has increased from 0.27 (Mar 24) to 0.44, marking an increase of 0.17.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.39. This value exceeds the healthy maximum of 1. It has increased from 1.36 (Mar 24) to 1.39, marking an increase of 0.03.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.56. It has decreased from 0.72 (Mar 24) to 0.56, marking a decrease of 0.16.
• For Current Ratio (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1.5. It has decreased from 0.92 (Mar 24) to 0.91, marking a decrease of 0.01.
• For Quick Ratio (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from 0.25 (Mar 24) to 0.27, marking an increase of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.77. This value is below the healthy minimum of 4. It has increased from 1.26 (Mar 24) to 1.77, marking an increase of 0.51.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 25.90 (Mar 24) to 0.00, marking a decrease of 25.90.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 12.35 (Mar 24) to 0.00, marking a decrease of 12.35.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 74.10 (Mar 24) to 0.00, marking a decrease of 74.10.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 87.65 (Mar 24) to 0.00, marking a decrease of 87.65.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 3. It has decreased from 2.25 (Mar 24) to 0.56, marking a decrease of 1.69.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.08. This value is below the healthy minimum of 3. It has decreased from 1.48 (Mar 24) to -0.08, marking a decrease of 1.56.
• For Enterprise Value (Cr.), as of Mar 25, the value is 552.47. It has decreased from 630.79 (Mar 24) to 552.47, marking a decrease of 78.32.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.22. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.22, marking an increase of 0.07.
• For EV / EBITDA (X), as of Mar 25, the value is 28.60. This value exceeds the healthy maximum of 15. It has increased from 9.18 (Mar 24) to 28.60, marking an increase of 19.42.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.48 (Mar 24) to 0.37, marking a decrease of 0.11.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 74.09 (Mar 24) to 0.00, marking a decrease of 74.09.
• For Price / BV (X), as of Mar 25, the value is 0.61. This value is below the healthy minimum of 1. It has decreased from 0.99 (Mar 24) to 0.61, marking a decrease of 0.38.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.48 (Mar 24) to 0.37, marking a decrease of 0.11.
• For EarningsYield, as of Mar 25, the value is -0.21. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 24) to -0.21, marking a decrease of 0.26.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness